Hematopoietic growth factors in cancer chemotherapy.

Published

Journal Article (Review)

Hematopoietic growth factors have made a significant impact on the treatment of cancer, primarily in the prevention of infections associated with chemotherapy-induced neutropenia, in progenitor cell transplantation, in chemotherapy-induced thrombocytopenia, and in chemotherapy-induced anemia. As seen with this review, our basic understanding of hematopoietic growth factors and their clinical potential continue to expand. Work will need to continue, especially with the new thrombopoietic factors, megakaryocyte growth and developing factor, thrombopoietin, and IL-11, to fully categorize their biology and clinical characteristics.

Full Text

Duke Authors

Cited Authors

  • Crawford, J; Foote, M; Morstyn, G

Published Date

  • 1999

Published In

Volume / Issue

  • 18 /

Start / End Page

  • 250 - 267

PubMed ID

  • 10800487

Pubmed Central ID

  • 10800487

International Standard Serial Number (ISSN)

  • 0921-4410

Language

  • eng

Conference Location

  • Netherlands